Proactive Investors - Run By Investors For Investors

Ellex Medical Lasers Ltd to outline placement details

Ellex Medical Lasers Ltd to outline placement details

Ellex Medical Lasers Ltd (ASX:ELX) has been granted a trading halt by the ASX, pending details of a placement.

Shares in the company recently hit a 12-month high of $0.90, and last traded at $0.77 before the halt was called.

This is three times higher than where the company was trading a year ago.

The halt will remain in place until the opening of trade on Friday 8th April 2016, or earlier if an announcement is made to the market.

 

Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

View full ELX profile View Profile

Ellex Medical Lasers Timeline

Newswire
November 30 2016

Related Articles

Scientist
December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
Proton Therapy sign
October 10 2018
The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies
CBD oil
November 16 2018
The company’s technology creates nano-scale emulsion mixtures that allow fluids to mix that normally don’t mix, such as CBD oil and water

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use